Fluticasone propionate/salmeterol xinafoate: Phase III start

This month, Mylan will begin a double-blind, placebo-controlled, U.S. Phase III trial to compare bioequivalence of inhaled MGR001 vs. Advair fluticasone propionate/salmeterol administered via the Dis...